Mirador Therapeutics, Inc.
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-04-034/3/24 | New | $80,000,000 | $80,000,000 | Equity Only | 06b | SEC linkSEC |
| 2024-04-034/3/24 | New | $332,999,976 | $332,999,976 | Equity Only | 06b | SEC linkSEC |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Timothy K. Andrews | Executive |
| Paul Berns | Director |
| David Bonita, M.D. | Director |
| Vika Brough | Executive |
| Kristina Burow | Director |
| Scott Glenn | Director |
| Mark C. Mc Kenna | Director, Executive |
| Joseph Papa | Director |
Industry: Other Health Care (See others in industry)
Address:
3115 Merryfield Row, Suite 210
San Diego, CA, 92121
Phone: (858) 523-5400
San Diego, CA, 92121
Phone: (858) 523-5400